|
| Analysis of patient’s blood | Day 1 | Day 2 | Day 16 |
|
| C-reactive protein, mg/dL (0.0–0.5) | <0.06 | <0.06 | — |
| Interleukin-6, ng/L (0.0–100.0) | 7.8 | — | — |
| White blood cell count, ×109/L (13.0–38.0) | 15.1 | 10.1 | 11.6 |
| Neutrophil count, ×109/L (2.0–7.0) | 3.6 | 5.1 | 1.8 |
| Lymphocyte count, ×109/L (3.38-21.6) | 10.12 | 3.81 | 8.54 |
| Segmented granulocytes, % (23.0–58.0) | 24.0 | 50.7 | 15.9 |
| Eosinophils, % (0.0–7.0) | 1.0 | 0.7 | 4.3 |
| Basophils, % (0.0–2.0) | 0.0 | 0.0 | 0.0 |
| Monocytes, % (8.0–13.0) | 8.0 | 10.1 | 5.8 |
| Lymphocytes, % (26.0–57.0) | 67.0 | 37.8 | 73.9 |
| Normoblasts, % (0.0-0.0) | 4.5 | 1.7 | — |
| Myelocytes, % (0.0-0.0) | — | 0.7 | — |
| Erythrocytes, ×1012/L (4.5–6.2) | 3.8 | 3.34 | 3.28 |
| Hemoglobin, g/L (140–230) | 142 | 121 | 116 |
| Hematocrit, L/L (0.45–0.62) | 0.386 | 0.323 | 0.320 |
| Mean corpuscular hemoglobin (MCH), pg (33.0–40.0) | 37.4 | 36.2 | 35.4 |
| Mean corpuscular volume (MCV), fL (91.0–102.0) | 101.6 | 96.7 | 97.6 |
| Mean corpuscular hemoglobin concentration (MCHC), g/L (300–370) | 368 | 375 | 363 |
| Red cell distributional width (RDW), % (11.5–14.4) | 16.9 | 15.9 | 13.9 |
| Platelet count, ×109/L (213–515) | 512 | 288 | 637 |
| Immature platelets, % (0.8–6.3) | 2.5 | 2.4 | |
| Immature platelet count, ×109/L (2.3–12.7) | 12.8 | 6.9 | |
| Fragmentocytes count,/HPF (0-1) | 3–5 | 3–5 | 3–5 |
| Reticulocytes, % (0–10) | — | 62.2 | — |
| Reticulocytes count, ×109/L (0–60) | — | 207.7 | — |
| Alanine aminotransferase, U/L (4–49) | — | — | 24 |
| Aspartate aminotransferase, U/L (14–77) | — | — | 8 |
| Gamma-glutamyl transferase, U/L (8–178) | — | — | 100 |
| Alkaline phosphatase, U/L (83–248) | — | — | 315 |
| Total bilirubin, mg/dL (0.1–12.6) | 2.0 | 8.6 | 9.6 |
| Direct bilirubin, mg/dL (0.0–2.1) | — | — | 0.63 |
| Urea, mg/dL (9.0–41.0) | — | — | 18.8 |
| Creatinine, mg/dL (0.3–0.7) | — | — | 0.34 |
|
